Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 29, 2016Critical CareOpen Access

Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan

View Full Paper
Ask AI
Bookmark
Share

Authors

KYKazuma YamakawaOsaka Medical and Pharmaceutical UniversityYUYutaka UmemuraOsaka Prefectural Medical CenterMHMineji HayakawaHokkaido University Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yamakawa et al. (2016) studied this question.

synapsesocial.com/papers/6a852f81f76e40547ac2aadahttps://doi.org/10.1186/s13054-016-1415-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis2015 · 71 citations
  2. 2Effect of a selective neutrophil elastase inhibitor on mortality and ventilator-free days in patients with increased extravascular lung water: a post hoc analysis of the PiCCO Pulmonary Edema Study2014 · 108 citations
  3. 3Cortistatin as a therapeutic target in inflammation2006 · 15 citations
  4. 4Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation2001 · 2,319 citations
  5. 5Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis2001 · 6,161 citations